Shopping Cart
- Remove All
Your shopping cart is currently empty
Ulixertinib hydrochloride (Ulixertinib HCl) is an orally available, selective and potent ERK1/2 inhibitor with anticancer and antitumor activity that inhibits the NB cell cycle and promotes apoptosis, and may be used in the study of solid tumors.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $35 | In Stock | |
| 5 mg | $56 | In Stock | |
| 10 mg | $89 | In Stock | |
| 25 mg | $143 | In Stock | |
| 50 mg | $198 | In Stock | |
| 100 mg | $372 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $62 | In Stock |
| Description | Ulixertinib hydrochloride (Ulixertinib HCl) is an orally available, selective and potent ERK1/2 inhibitor with anticancer and antitumor activity that inhibits the NB cell cycle and promotes apoptosis, and may be used in the study of solid tumors. |
| In vitro | Combined treatment with Ulixertinib hydrochloride and VS-5584 for 48 hours significantly induced cell death in human pancreatic adenocarcinoma (HPAC) cells from the PDAC cell lines BxPC-3, MIAPaCa-2 and CFPAC. [1] |
| In vivo | Ulixertinib hydrochloride potently inhibited neuroblastoma tumor growth and prolonged the overall survival of the treated mice in two different neuroblastoma mice models. [2] |
| Molecular Weight | 469.79 |
| Formula | C21H23Cl3N4O2 |
| Cas No. | 1956366-10-1 |
| Smiles | ClC1=C(C=2C=C(C(N[C@H](CO)C3=CC(Cl)=CC=C3)=O)NC2)C=C(NC(C)C)N=C1.Cl |
| Relative Density. | no data available |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: < 0.1 mg/mL(insoluble) DMSO: 80 mg/mL (170.29 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.